ATE148108T1 - Beta,beta-dimethyl-4-piperidinethanamin-derivat als inhibitoren der cholesterin-biosynthese - Google Patents
Beta,beta-dimethyl-4-piperidinethanamin-derivat als inhibitoren der cholesterin-biosyntheseInfo
- Publication number
- ATE148108T1 ATE148108T1 AT94916294T AT94916294T ATE148108T1 AT E148108 T1 ATE148108 T1 AT E148108T1 AT 94916294 T AT94916294 T AT 94916294T AT 94916294 T AT94916294 T AT 94916294T AT E148108 T1 ATE148108 T1 AT E148108T1
- Authority
- AT
- Austria
- Prior art keywords
- beta
- inhibitors
- pct
- dimethyl
- cholesterol biosynthesis
- Prior art date
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title abstract 4
- 239000003112 inhibitor Substances 0.000 title abstract 3
- DLJOMROFDXIQBW-UHFFFAOYSA-N 2-methyl-2-piperidin-4-ylpropan-1-amine Chemical class NCC(C)(C)C1CCNCC1 DLJOMROFDXIQBW-UHFFFAOYSA-N 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 235000012000 cholesterol Nutrition 0.000 title abstract 2
- PUERAZFQIXLYDR-CQNOQWDGSA-N 3-[(4e,8e,12e,16e)-4,8,13,17,21-pentamethyldocosa-4,8,12,16,20-pentaenylidene]oxetane Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CCC=C1COC1 PUERAZFQIXLYDR-CQNOQWDGSA-N 0.000 abstract 1
- 101710095468 Cyclase Proteins 0.000 abstract 1
- 239000003429 antifungal agent Substances 0.000 abstract 1
- 230000000055 hyoplipidemic effect Effects 0.000 abstract 1
- 230000000871 hypocholesterolemic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9305915A FR2705343B1 (fr) | 1993-05-17 | 1993-05-17 | Dérivés de beta,beta-diméthyl-4-pipéridineéthanamine, leur procédé de préparation et leur utilisation en thérapeutique. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE148108T1 true ATE148108T1 (de) | 1997-02-15 |
Family
ID=9447204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94916294T ATE148108T1 (de) | 1993-05-17 | 1994-05-17 | Beta,beta-dimethyl-4-piperidinethanamin-derivat als inhibitoren der cholesterin-biosynthese |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5614534A (de) |
| EP (1) | EP0699187B1 (de) |
| JP (1) | JPH08510726A (de) |
| AT (1) | ATE148108T1 (de) |
| CA (1) | CA2163001A1 (de) |
| DE (1) | DE69401584T2 (de) |
| ES (1) | ES2098947T3 (de) |
| FR (1) | FR2705343B1 (de) |
| WO (1) | WO1994026713A1 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4410822A1 (de) * | 1994-03-24 | 1995-09-28 | Schering Ag | Neue Piperidin-Derivate |
| US6964974B2 (en) | 2000-09-08 | 2005-11-15 | Hoffmann-La Roche Inc. | 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| TWI350168B (en) | 2004-05-07 | 2011-10-11 | Incyte Corp | Amido compounds and their use as pharmaceuticals |
| US20060009491A1 (en) * | 2004-06-24 | 2006-01-12 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
| EP1758882A4 (de) * | 2004-06-24 | 2008-01-23 | Incyte Corp | Amidverbindungen und ihre verwendung als arzneimittel |
| JP2008504278A (ja) * | 2004-06-24 | 2008-02-14 | インサイト・コーポレイション | アミド化合物およびその医薬としての使用 |
| CA2570637A1 (en) | 2004-06-24 | 2006-02-02 | Wenqing Yao | N-substituted piperidines and their use as pharmaceuticals |
| CA2584502A1 (en) | 2004-06-24 | 2006-01-05 | Incyte Corporation | 2-methylpropanamides and their use as pharmaceuticals |
| CN101080226A (zh) * | 2004-08-10 | 2007-11-28 | 因塞特公司 | 酰氨基化合物及它们作为药物的用途 |
| AU2005304560C1 (en) * | 2004-11-10 | 2013-05-09 | Incyte Holdings Corporation | Lactam compounds and their use as pharmaceuticals |
| US8110581B2 (en) | 2004-11-10 | 2012-02-07 | Incyte Corporation | Lactam compounds and their use as pharmaceuticals |
| BRPI0518281A2 (pt) * | 2004-11-18 | 2008-11-18 | Incyte Corp | inibidores de 11-beta hidroxilesteràide desidrogenase do tipo i e mÉtodos uso dos mesmos |
| WO2007038138A2 (en) * | 2005-09-21 | 2007-04-05 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
| TW200804382A (en) * | 2005-12-05 | 2008-01-16 | Incyte Corp | Lactam compounds and methods of using the same |
| US7998959B2 (en) * | 2006-01-12 | 2011-08-16 | Incyte Corporation | Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same |
| KR20080091503A (ko) * | 2006-01-31 | 2008-10-13 | 인사이트 코포레이션 | 아미도 화합물 및 약제로서의 이의 용도 |
| WO2007101270A1 (en) * | 2006-03-02 | 2007-09-07 | Incyte Corporation | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| WO2007103719A2 (en) * | 2006-03-03 | 2007-09-13 | Incyte Corporation | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| WO2007130898A1 (en) * | 2006-05-01 | 2007-11-15 | Incyte Corporation | TETRASUBSTITUTED UREAS AS MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1 |
| US7838544B2 (en) * | 2006-05-17 | 2010-11-23 | Incyte Corporation | Heterocyclic inhibitors of 11-β hydroxyl steroid dehydrogenase type 1 and methods of using the same |
| BRPI0713517B1 (pt) | 2006-06-23 | 2019-12-17 | Kba Giori Sa | dispositivo de numeração para numeração tipográfica |
| CL2008001839A1 (es) | 2007-06-21 | 2009-01-16 | Incyte Holdings Corp | Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades. |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB991509A (en) * | 1963-10-15 | 1965-05-12 | Parke Davis & Co | Aminoalkylpiperidinoalkyl-ª‡-naphthylamines |
| US4248877A (en) * | 1973-06-22 | 1981-02-03 | Sandoz Ltd. | Organic compounds |
| JPS5195049A (en) * | 1975-02-12 | 1976-08-20 | * **********so*****no***tsu*****************************************ni*no | |
| US4473694A (en) * | 1981-04-03 | 1984-09-25 | The B. F. Goodrich Company | Process for the preparation of polysubstituted α-aminoacetamides |
| US4569933A (en) * | 1984-04-13 | 1986-02-11 | Cornu Pierre Jean | Antihypertensive substituted derivatives of 2,5-diamino 1,4-diazole |
| PT86427B (pt) * | 1986-12-22 | 1990-11-20 | Zambeletti Spa L | Processo para a preparacao de derivados de piperidina |
| US4939161A (en) * | 1989-05-12 | 1990-07-03 | Boc, Inc. | Analgesic N-aryl-N-[1-substituted-3,5-dimethyl-4-piperidinyl]amides |
| CA2025490C (en) * | 1989-09-22 | 2003-09-16 | James R. Mccarthy | Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis |
| CA2047389C (en) * | 1990-07-24 | 2002-04-23 | James R. Mccarthy | Substituted piperidines and their use as inhibitors of cholesterol synthesis |
| JP3026845B2 (ja) * | 1991-02-20 | 2000-03-27 | 日清製粉株式会社 | ピペリジン誘導体 |
-
1993
- 1993-05-17 FR FR9305915A patent/FR2705343B1/fr not_active Expired - Fee Related
-
1994
- 1994-05-17 JP JP6525084A patent/JPH08510726A/ja active Pending
- 1994-05-17 US US08/545,626 patent/US5614534A/en not_active Expired - Fee Related
- 1994-05-17 CA CA002163001A patent/CA2163001A1/en not_active Abandoned
- 1994-05-17 DE DE69401584T patent/DE69401584T2/de not_active Expired - Fee Related
- 1994-05-17 ES ES94916294T patent/ES2098947T3/es not_active Expired - Lifetime
- 1994-05-17 WO PCT/FR1994/000584 patent/WO1994026713A1/fr not_active Ceased
- 1994-05-17 AT AT94916294T patent/ATE148108T1/de not_active IP Right Cessation
- 1994-05-17 EP EP94916294A patent/EP0699187B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2098947T3 (es) | 1997-05-01 |
| FR2705343A1 (fr) | 1994-11-25 |
| FR2705343B1 (fr) | 1995-07-21 |
| EP0699187B1 (de) | 1997-01-22 |
| DE69401584D1 (de) | 1997-03-06 |
| DE69401584T2 (de) | 1997-05-22 |
| WO1994026713A1 (fr) | 1994-11-24 |
| US5614534A (en) | 1997-03-25 |
| EP0699187A1 (de) | 1996-03-06 |
| CA2163001A1 (en) | 1994-11-24 |
| JPH08510726A (ja) | 1996-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE148108T1 (de) | Beta,beta-dimethyl-4-piperidinethanamin-derivat als inhibitoren der cholesterin-biosynthese | |
| DK0666850T3 (da) | Derivater af 1,2,3,5,6,7,8,8a-octahydro-5, 5 , 8a-trimethyl-(8abeta)-6-isoquinolinamin, deres fremstillingsmåde og terapeutiske anvendelse | |
| AU2267395A (en) | Benzofuran derivatives useful as inhibitors of bone resorption | |
| PT958296E (pt) | Compostos heterociclicos processo para a sua preparacao composicoes farmaceuticas contendo-os e sua utilizacao no tratamento da diabetes e doencas relacionadas | |
| PL306590A1 (en) | Substituted heterocyclic carboxylamides, method obtaining them and their application as therapeutic agents | |
| BR9609888A (pt) | Halogenobenzimidazóis | |
| AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
| CA2176935A1 (fr) | Arylpiperazines derivees d'indole comme ligands pour les recepteurs 5 ht1-like 5 ht1b et 5 ht1d | |
| DK0874812T3 (da) | Hidtil ukendte 2,3,5-trimethyl-4-hydroxyanilidderivater, fremstilling deraf og terapeutisk anvendelse deraf | |
| AU2797695A (en) | Thiazolidine derivatives, their preparation and drugs containing same | |
| GEP20074045B (en) | (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease | |
| GB9121456D0 (en) | Triazole antifungal agents | |
| HUP0103303A2 (hu) | Imidazolvegyületek, eljárás előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
| DK0728138T3 (da) | Anthracyclinderivater | |
| DK0823909T3 (da) | Hidtil ukendte heterocykliske forbindelser | |
| ZA941964B (en) | Substituted (arylalkylaminobezyl) aminopropionamide derivatives and process for their preparation | |
| AU6991696A (en) | 3-beta-aminoazabicyclo-octane or -nonane naphthamide derivatives as antipsychotic agents | |
| PT99280A (pt) | Processo de preparacao de derivados do indolo e de composicoes farmaceuticas | |
| BR9508481A (pt) | Nova utilização e novos derivados do imidazol seu processo de preparação os novos intermediários obtidos sua aplicação a título de medicamentos e as composições farmacéuticas que contém os mesmos | |
| HUT76838A (en) | Imidazole derivatives, method for preparing same and pharmaceutical compositions containing same, so as their intermediates | |
| DE69528984D1 (de) | Hemmung der leukotrienbiosynthese mittels harnstoffderivaten | |
| BR1100189A (pt) | Derivados de carboestirila |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |